Skip to main content
Top
Published in: Clinical & Experimental Metastasis 6/2010

01-08-2010 | Research Paper

Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution

Authors: Laila Illán Rubio, Bertrand Tavitian, Elina Zueva

Published in: Clinical & Experimental Metastasis | Issue 6/2010

Login to get access

Abstract

We compared gene expression patterns related to cancer progression, cell adhesion and cytokine expression in v-Src-transformed isogenic cell lines with different levels of metastatic aggressiveness in syngenic animals: a high (HM) and a low metastatic (LM) cell lines, both predetermined by in vitro oncogenic transformation, and a high metastatic (NM) cell line resulting from in vivo selection of grafted LM cells. While LM and NM shared a common v-Src transforming variant different from that of HM, gene expression patterns were similar in HM and NM but different from that of LM. In this model, the induction of the metastatic phenotype by an oncogene variant or by the host environment led to highly similar expression profiles. If confirmed in other models, these results would be relevant for the diagnosis and treatment of metastasis.
Literature
1.
go back to reference Fidler IJ (1973) Selection of successive tumour lines for metastasis. Nat New Biol 242:148–149PubMed Fidler IJ (1973) Selection of successive tumour lines for metastasis. Nat New Biol 242:148–149PubMed
2.
go back to reference Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524CrossRefPubMed Minn AJ, Gupta GP, Siegel PM et al (2005) Genes that mediate breast cancer metastasis to lung. Nature 436:518–524CrossRefPubMed
3.
go back to reference Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54CrossRefPubMed Ramaswamy S, Ross KN, Lander ES, Golub TR (2003) A molecular signature of metastasis in primary solid tumors. Nat Genet 33:49–54CrossRefPubMed
4.
go back to reference Fan C, Oh DS, Wessels L et al (2006) Concordance among gene-expression based predictors for breast cancer. N Engl J Med 355:560–569CrossRefPubMed Fan C, Oh DS, Wessels L et al (2006) Concordance among gene-expression based predictors for breast cancer. N Engl J Med 355:560–569CrossRefPubMed
5.
go back to reference Weinberg RA (2008) Mechanisms of malignant progression. Carcinogenesis 6:1092–1095CrossRef Weinberg RA (2008) Mechanisms of malignant progression. Carcinogenesis 6:1092–1095CrossRef
6.
go back to reference Egan S, Wright J, Jarolin L et al (1987) Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 23:202–205CrossRef Egan S, Wright J, Jarolin L et al (1987) Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 23:202–205CrossRef
7.
go back to reference Soker A, Sieweke M (1989) v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus. Proc Natl Acad Sci USA 86:10123–10127CrossRef Soker A, Sieweke M (1989) v-src induces clonal sarcomas and rapid metastasis following transduction with a replication-defective retrovirus. Proc Natl Acad Sci USA 86:10123–10127CrossRef
8.
go back to reference Deichman GI, Kashleva HA, Kluchareva TE, Matveeva VA (1989) Clustering of discrete cell properties essential for tumorigenicity and metastasis II. Studies of Syrian hamster embyo fibroblasts transformed by Rous Sarcoma Virus. Int J Cancer 44:908–910CrossRefPubMed Deichman GI, Kashleva HA, Kluchareva TE, Matveeva VA (1989) Clustering of discrete cell properties essential for tumorigenicity and metastasis II. Studies of Syrian hamster embyo fibroblasts transformed by Rous Sarcoma Virus. Int J Cancer 44:908–910CrossRefPubMed
9.
go back to reference Tatosyan A, Yatsula B, Shtutman M et al (1996) Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells. Virology 216:347–356CrossRefPubMed Tatosyan A, Yatsula B, Shtutman M et al (1996) Two novel variants of the v-src oncogene isolated from low and high metastatic RSV-transformed hamster cells. Virology 216:347–356CrossRefPubMed
10.
go back to reference Deichman GI, Gurova KV, Dyakova NA (1994) Accumulation in “normal” lungs of live tumorigenic cells during sub-cutaneous growth of weakly and highly metastasizing tumors and their in vitro sensitivity to growth regulation by normal fibroblasts. Int J Cancer 59:530–537CrossRefPubMed Deichman GI, Gurova KV, Dyakova NA (1994) Accumulation in “normal” lungs of live tumorigenic cells during sub-cutaneous growth of weakly and highly metastasizing tumors and their in vitro sensitivity to growth regulation by normal fibroblasts. Int J Cancer 59:530–537CrossRefPubMed
11.
go back to reference Deichman GI, Kashkina LM, Mizenina OA et al (1996) Mechanisms of unusually high antioxidant activity of RSV-transformed cells and of its suppression by activated p21ras. Int J Cancer 66:747–752CrossRefPubMed Deichman GI, Kashkina LM, Mizenina OA et al (1996) Mechanisms of unusually high antioxidant activity of RSV-transformed cells and of its suppression by activated p21ras. Int J Cancer 66:747–752CrossRefPubMed
12.
go back to reference Foty RA, Steinberg MS (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48:397–409CrossRefPubMed Foty RA, Steinberg MS (2004) Cadherin-mediated cell-cell adhesion and tissue segregation in relation to malignancy. Int J Dev Biol 48:397–409CrossRefPubMed
13.
go back to reference Kashima T, Nakamura K, Kawaguchi J et al (2003) Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 104:147–154CrossRefPubMed Kashima T, Nakamura K, Kawaguchi J et al (2003) Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo. Int J Cancer 104:147–154CrossRefPubMed
14.
go back to reference Poon RT, Chung KK, Cheung ST et al (2004) Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin Cancer Res 10:4150–4157CrossRefPubMed Poon RT, Chung KK, Cheung ST et al (2004) Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. Clin Cancer Res 10:4150–4157CrossRefPubMed
15.
go back to reference Secord AA, Darcy KM, Hutson A et al (2007) Gynecologic oncology group study. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol 106:221–232CrossRefPubMed Secord AA, Darcy KM, Hutson A et al (2007) Gynecologic oncology group study. Co-expression of angiogenic markers and associations with prognosis in advanced epithelial ovarian cancer: a gynecologic oncology group study. Gynecol Oncol 106:221–232CrossRefPubMed
16.
go back to reference Maeda K, Nishiguchi Y, Kang SM et al (2001) Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol Rep 8:763–766PubMed Maeda K, Nishiguchi Y, Kang SM et al (2001) Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer. Oncol Rep 8:763–766PubMed
17.
go back to reference Yamaguchi M, Sugio K, Ondo K, Yano T, Sugimachi K (2002) Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer. Lung Cancer 36:143–150CrossRefPubMed Yamaguchi M, Sugio K, Ondo K, Yano T, Sugimachi K (2002) Reduced expression of thrombospondin-1 correlates with a poor prognosis in patients with non-small cell lung cancer. Lung Cancer 36:143–150CrossRefPubMed
18.
go back to reference Takano Y, Kato Y, Masuda M et al (1999) Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189:194–200CrossRefPubMed Takano Y, Kato Y, Masuda M et al (1999) Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189:194–200CrossRefPubMed
19.
go back to reference Hans CP, Weisenburger DD, Greiner TC et al (2005) Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol 18:1377–1384CrossRefPubMed Hans CP, Weisenburger DD, Greiner TC et al (2005) Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphoma. Mod Pathol 18:1377–1384CrossRefPubMed
20.
go back to reference Schmalbach CE, Chepeha DB, Giordano TJ et al (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:295–302CrossRefPubMed Schmalbach CE, Chepeha DB, Giordano TJ et al (2004) Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130:295–302CrossRefPubMed
21.
go back to reference Roepman P, Wessels LF, Kettelarij N et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182–186CrossRefPubMed Roepman P, Wessels LF, Kettelarij N et al (2005) An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37:182–186CrossRefPubMed
22.
go back to reference Koon N, Schneider-Stock R, Sarlomo-Rikala M et al (2004) Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 53:235–240CrossRefPubMed Koon N, Schneider-Stock R, Sarlomo-Rikala M et al (2004) Molecular targets for tumour progression in gastrointestinal stromal tumours. Gut 53:235–240CrossRefPubMed
23.
go back to reference Vecchi M, Nuciforo P, Romagnoli S et al (2007) Gene expression analysis of early and advanced gastric cancers. Oncogene 26:4284–4294CrossRefPubMed Vecchi M, Nuciforo P, Romagnoli S et al (2007) Gene expression analysis of early and advanced gastric cancers. Oncogene 26:4284–4294CrossRefPubMed
24.
go back to reference Jones JL, Glynn P, Walker RA (1999) Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189:161–168CrossRefPubMed Jones JL, Glynn P, Walker RA (1999) Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol 189:161–168CrossRefPubMed
25.
go back to reference Mimori K, Ueo H, Shirasaka C, Mori M (2001) Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep 8:401–403PubMed Mimori K, Ueo H, Shirasaka C, Mori M (2001) Clinical significance of MT1-MMP mRNA expression in breast cancer. Oncol Rep 8:401–403PubMed
26.
go back to reference Kawanishi H, Matsui Y, Ito M et al (2008) Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res 14:2579–2587CrossRefPubMed Kawanishi H, Matsui Y, Ito M et al (2008) Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer. Clin Cancer Res 14:2579–2587CrossRefPubMed
27.
go back to reference Al-Rawi MA, Rmali K, Watkins G, Mansel RE, Jiang WG et al (2004) Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer 40:494–502CrossRefPubMed Al-Rawi MA, Rmali K, Watkins G, Mansel RE, Jiang WG et al (2004) Aberrant expression of interleukin-7 (IL-7) and its signalling complex in human breast cancer. Eur J Cancer 40:494–502CrossRefPubMed
28.
go back to reference Roato I, Brunetti G, Gorassini E et al (2006) IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One 1:e124CrossRefPubMed Roato I, Brunetti G, Gorassini E et al (2006) IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in patients affected by solid tumor. PLoS One 1:e124CrossRefPubMed
29.
go back to reference Teruya-Feldstein J, Jaffe ES, Burd PR et al (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463–2470PubMed Teruya-Feldstein J, Jaffe ES, Burd PR et al (1999) Differential chemokine expression in tissues involved by Hodgkin’s disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 93:2463–2470PubMed
30.
go back to reference Levina V, Nolen BM, Marrangoni AM et al (2009) Role of eotaxin-1 signaling in ovarian cancer. Clin Cancer Res 15:2647–2656CrossRefPubMed Levina V, Nolen BM, Marrangoni AM et al (2009) Role of eotaxin-1 signaling in ovarian cancer. Clin Cancer Res 15:2647–2656CrossRefPubMed
31.
go back to reference Thakur A, Bollig A, Wu J, Liao DJ (2008) Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice. Mol Cancer 7:11CrossRefPubMed Thakur A, Bollig A, Wu J, Liao DJ (2008) Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice. Mol Cancer 7:11CrossRefPubMed
32.
go back to reference Mita K, Zhang Z, Ando Y et al (2007) Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer. Jpn J Clin Oncol 37:575–582CrossRefPubMed Mita K, Zhang Z, Ando Y et al (2007) Prognostic significance of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 expression in breast cancer. Jpn J Clin Oncol 37:575–582CrossRefPubMed
33.
go back to reference Lu Z, Jiang G, Blume-Jensen P, Hunter T (2001) Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21:4016–4031CrossRefPubMed Lu Z, Jiang G, Blume-Jensen P, Hunter T (2001) Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase. Mol Cell Biol 21:4016–4031CrossRefPubMed
34.
go back to reference Malek RL, Irby RB, Guo QM et al (2002) Identification of Src transformation fingerprint in human colon cancer. Oncogene 21:256–265CrossRef Malek RL, Irby RB, Guo QM et al (2002) Identification of Src transformation fingerprint in human colon cancer. Oncogene 21:256–265CrossRef
Metadata
Title
Similar expression profiles of a core of genes and proteins in cells that have acquired a metastatic phenotype, genetically or by in vivo evolution
Authors
Laila Illán Rubio
Bertrand Tavitian
Elina Zueva
Publication date
01-08-2010
Publisher
Springer Netherlands
Published in
Clinical & Experimental Metastasis / Issue 6/2010
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-009-9297-0

Other articles of this Issue 6/2010

Clinical & Experimental Metastasis 6/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine